Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease.

Potter, A

Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease. [electronic resource] - Psychopharmacology Mar 1999 - 334-42 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0033-3158

10.1007/s002130050897 doi


Aged
Alzheimer Disease--drug therapy
Cognition--drug effects
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Hydrocortisone--blood
Isoxazoles--blood
Learning--drug effects
Male
Memory--drug effects
Middle Aged
Nicotinic Agonists--pharmacology
Prolactin--blood
Psychomotor Performance--drug effects
Pyrrolidines--blood